[artículo] 
inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 2 (Abril) . - pp. 176-181

Título :	Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium
Tipo de documento:	texto impreso
Autores:	Robert Lynn Horne, Autor ; Cedric Cunanan, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 176-181
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antimaníacos, Trastornos mentales - diagnóstico, Acido Valproico.
Resumen:	This study evaluated the safety and efficacy of divalproex sodium extended-release (ER) when patients were switched from therapy with divalproex sodium delayed-release (DR) to divalproex sodium ER. This open-label, 7-day study included 55 patients with bipolar disorder, major depression, schizophrenia, schizoaffective disorder, Alzheimer’s disease, dementia, or intermittent explosive disorder.
Link:	./index.php?lvl=notice_display&id=31035

[artículo] Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium [texto impreso] / Robert Lynn Horne, Autor ; Cedric Cunanan, Autor . - 2023 . - pp. 176-181.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 2 (Abril) . - pp. 176-181

Palabras clave:	Antimaníacos, Trastornos mentales - diagnóstico, Acido Valproico.
Resumen:	This study evaluated the safety and efficacy of divalproex sodium extended-release (ER) when patients were switched from therapy with divalproex sodium delayed-release (DR) to divalproex sodium ER. This open-label, 7-day study included 55 patients with bipolar disorder, major depression, schizophrenia, schizoaffective disorder, Alzheimer’s disease, dementia, or intermittent explosive disorder.
Link:	./index.php?lvl=notice_display&id=31035